Accuray Incorporated (ARAY) Financials
ARAY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 447.6 million | 405.9 million |
| Dec. 31, 2025 | 448.0 million | 394.6 million |
| Sept. 30, 2025 | 456.8 million | 394.9 million |
| June 30, 2025 | 470.2 million | 389.1 million |
ARAY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -7.1 million | 1.4 million |
| Dec. 31, 2025 | -17.1 million | 882000 |
| Sept. 30, 2025 | 8.4 million | 2.5 million |
| June 30, 2025 | -13.1 million | 2.8 million |
ARAY Net Income
No data available :(
ARAY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 38.1 million | 134.0 million | 37.2 million |
| Dec. 31, 2025 | 41.3 million | 155.0 million | 30.2 million |
| Sept. 30, 2025 | 63.9 million | 127.3 million | 38.9 million |
| June 30, 2025 | 57.4 million | 123.8 million | 39.9 million |
ARAY Shares Outstanding
ARAY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 1.5 million | 8.2 million | 19.7 million | 8.4 million |
| Dec. 31, 2025 | 1.1 million | 10.7 million | 18.9 million | 8.8 million |
| Sept. 30, 2025 | 3.8 million | 11.4 million | 26.5 million | 12.0 million |
| June 30, 2025 | 3.4 million | 11.5 million | 23.3 million | 11.4 million |
ARAY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 104.8 million | 79.6 million |
| Dec. 31, 2025 | 102.2 million | 78.2 million |
| Sept. 30, 2025 | 93.9 million | 67.4 million |
| June 30, 2025 | 127.5 million | 88.6 million |
ARAY Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ARAY
Price: $0.35
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 811938
Ebitda: 1.5 millionMarket Capitalization: 40.7 million